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Abstract. The endocytic protein dynamin participates in 
the formation of actin-based membrane protrusions such as 
podosomes, pseudopodia, and invadopodia, which facilitate 
cancer cell migration, invasion, and metastasis. However, the 
role of dynamin in the formation of actin-based membrane 
protrusions at the leading edge of cancer cells is unclear. In 
this study, we demonstrate that the ubiquitously expressed 
dynamin 2 isoform facilitates cell migration by stabilizing 
F-actin bundles in filopodia of the lung cancer cell line H1299. 
Pharmacological inhibition of dynamin 2 decreased cell 
migration and filopodial formation. Furthermore, dynamin 2 
and cortactin mostly colocalized along F-actin bundles in 
filopodia of serum-stimulated H1299 cells by immuno-
fluorescent and immunoelectron microscopy. Knockdown of 
dynamin 2 or cortactin inhibited the formation of filopodia 
in serum-stimulated H1299 cells, concomitant with a loss of 
F-actin bundles. Expression of wild-type cortactin rescued the 
punctate-like localization of dynamin 2 and filopodial forma-
tion. The incubation of dynamin 2 and cortactin with F-actin 
induced the formation of long and thick actin bundles, with 
these proteins colocalizing at F-actin bundles. A depolymer-
ization assay revealed that dynamin 2 and cortactin increased 
the stability of F-actin bundles. These results indicate that 
dynamin 2 and cortactin participate in cell migration by 
stabilizing F-actin bundles in filopodia. Taken together, these 
findings suggest that dynamin might be a possible molecular 
target for anticancer therapy.
Introduction
Cancer cell migration, invasion, and metastasis are preceded 
by the formation of pseudopodia such as lamellipodia and 
filopodia. During these cellular processes, F-actin filaments 
remodel into a higher order structure and then assemble 
an intricate cytoskeletal network within cells (1). These 
dynamic three-dimensional changes are mediated by several 
actin-bundling and crosslinking proteins, and are essential 
for supporting filopodia at the leading edge of migrating 
cells (2).
Dynamin plays an essential role in endocytosis, partici-
pating in the membrane fission process (3-5). Dynamin also 
functions in the formation of actin-rich structures, including 
lamellipodia and dorsal membrane ruffles (6,7), invadopodia 
(8), podosomes (9), growth cones (10-12), and phagocytic cups 
(13,14). Three dynamin isoforms exist, namely, dynamin 1, 2, 
and 3 (5). Dynamins are characterized by a GTPase domain 
at the N-terminus, a bundle signaling element, a stalk domain, 
a phosphoinositide-binding pleckstrin homology domain, 
and a proline and arginine-rich domain at the C-terminus 
(PRD) (15,16). The PRD interacts with different proteins that 
contain the Src-homology-3 (SH3) domain. Of these GTPases, 
dynamin 2 is ubiquitously expressed.
Cortactin, an F-actin-binding protein, was first identified 
as an Src substrate (17). Cortactin also participates in cancer 
cell migration, invasion, and metastasis by regulating actin 
dynamics at the leading edge of migrating cells (18). Cortactin 
is composed of an N-terminal acidic domain and a six-and-a-
half tandem repeats domain, which directly binds to F-actin. 
Cortactin also contains an α-helix, a proline-rich region, and 
an SH3 domain at the C-terminus, which interacts with the 
PRD of several binding partners (19).
Both dynamin and cortactin are implicated in the dynamics 
of cancer cells, including migration, invasion, and metastasis 
(18). In addition, the pharmacological inhibition of dynamin 
by GTPase inhibitors suppresses specific cellular processes 
such as the lamellipodial formation and invasion of human 
osteocarcinoma cells (20) and the growth of human prostate 
adenocarcinoma cells (21).
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A previous study reported that dynamin 2 binds to 
cortactin (7,12). A disruption of this protein complex can 
affect the shape of cancer cells (7), organization of the F-actin 
network within these cells (22), and structure of growth cones 
(11,12). However, the role of the dynamin 2-cortactin complex 
in the dynamics of the actin cytoskeleton in cancer cells is 
unclear. In this study, we investigated whether dynamin 2 and 
cortactin regulate the F-actin bundle formation in filopodia in 
the human non-small cell lung carcinoma cell line H1299.
Materials and methods
Antibodies and reagents. Rabbit polyclonal anti-dynamin 1 (cat. 
no. PA1-660; Thermo Fisher Scientific, Waltham, MA, USA) 
and anti-c-myc (cat. no. C3956; Sigma-Aldrich, St. Louis, MO, 
USA) antibodies, and a goat polyclonal anti-dynamin 2 (cat. 
no. sc-6400; Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
antibody, were purchased. In addition, mouse monoclonal 
anti-β-actin (cat. no. A5441, Sigma-Aldrich), Dynasore (cat. 
no. D7693, Sigma-Aldrich), anti-c-myc (cat. no. sc-40; Santa 
Cruz Biotechnology), anti-green fluorescent protein (GFP; cat. 
no. sc-9996, Santa Cruz Biotechnology), and anti-cortactin 
(cat. no. 05-180; EMD Millipore, Darmstadt, Germany) 
antibodies were purchased. MitMAB and Dynole 34-2 were 
purchased from Abcam Biochemicals (Bristol, UK). Alexa 
Fluor 488-conjugated anti-rabbit IgG, rhodamine-conjugated 
anti-mouse IgG, and rhodamine or Alexa Fluor 488-labeled 
phalloidin were obtained from Thermo Fisher Scientific. 
Purified rabbit skeletal α-actinin was purchased from 
Cytoskeleton, Inc. (Denver, CO, USA). Goat anti-mouse 
IgG- and goat anti-rabbit IgG-conjugated gold particles were 
purchased from British BioCell International (Cardiff, UK).
Cell culture. The human non-small cell lung carcinoma cell 
line H1299 (Cat. no. ATCC CRL-5803; American Type Culture 
Collection, Manassas, VA, USA) was cultured in Dulbecco's 
modified Eagle's medium (DMEM, Thermo Fisher Scientific) 
supplemented with 10% fetal bovine serum (FBS) at 37˚C in 
an atmosphere of 5% CO2.
Expression and purification of dynamin 2 and cortactin 
wild-types and mutants. GFP-tagged dynamin 2 cloned into 
pEGFP-N1 was a kind gift from Dr Mark McNiven (Mayo 
Clinic, Rochester, MN, USA) (6). His-tagged dynamin 2 
produced with the Bac-to-Bac baculovirus expression system 
(Thermo Fisher Scientific) was a kind gift from Dr Hiroshi 
Handa (Tokyo Institute of Technology, Tokyo, Japan) (23). The 
dynamin solution was concentrated using a Centriplus YM50 
(Thermo Fisher Scientific) and stored at -80˚C. The protein 
suspension (2-5 mg/ml protein) was thawed at 37˚C before use.
The cDNAs encoding full-length rat cortactin and its 
mutants were prepared by polymerase chain reaction ampli-
fication using specific primers (12). Full-length cortactin or 
1-450aa (Cort ∆SH3) was subcloned into the plasmid pGEX-6p 
vector as BamHI-EcoRI fragments. GST-tagged cortactin 
W525K was generated by mutating pGEX-6p-cortactin with 
the QuickChange site-directed mutagenesis kit (Agilent 
Technologies, Santa Clara, CA, USA). For expression in cells, 
full-length cortactin or Cort ∆SH3 was subcloned into the pEF1 
myc-His vector (Thermo Fisher Scientific) as EcoRI-XbaI 
fragments. The nucleotide sequences of the constructs were 
verified by DNA sequence analysis. The resulting plasmid was 
transformed into the bacterial BL21 (DE3) pLysS strain for 
protein expression. The expression of GST-fusion proteins was 
induced by 0.1 mM isopropyl-1-thio-d-galactopyranoside at 
37˚C for 3-6 h in LB medium supplemented with 100 µg/ml 
ampicillin to A600 = 0.8. The purification of GST-fusion proteins 
was performed as previously described (24), and the cleavage 
of the GST with PreScission protease was performed according 
to the manufacturer's instructions. The protein was purified on 
a MonoQ column equilibrated in 20 mM Tris-HCl and 0.2 M 
NaCl, pH 7.7. The eluted protein fraction (1 mg/ml protein) 
was stored at -80˚C. For the pull-down assay, the proteins were 
used without cleaving GST.
siRNA-mediated interference. Pre-annealed siRNAs for human 
dynamin 2 and cortactin, and the negative control siRNA, 
were synthesized and purified (Thermo Fisher Scientific). 
The sequences for the siRNAs for human dynamin 2 were as 
follows: 5'-GGAUAUUGAGGGCAAGAAGtt-3' (sense), 
5'-CUUCUUGCCCUCAAUAUCCtt-3' (antisense) for oligo 1; 
5'-GCGAAUCGUCACCACUUACtt-3' (sense), 5'-GUAAGUG 
GUGACGAUUCGCtc-3' (antisense) for oligo 2; and 5'-GGAC 
UUACGACGGGAGAUCtt-3' (sense), 5'-GAUCUCCCGU 
CGUAAGUCCtt-3' (antisense) for oligo 3. The sequences for 
the siRNAs for human cortactin were as follows: CCGAAUG 
GAUAAGUCAGUCtt-3' (sense), 5'-AGCUGACUUAUCCAU 
UCGGtc-3' (antisense) for oligo 1; GGUUUCGGCGGCA 
AAUACGtt-3' (sense), CGUAUUUGCCGCCGAAACCtt-3' 
(antisense) for oligo 2; and CGAAUAUCAGUCGAAACUUtt-3' 
(sense), AAGUUUCGACUGAUAUUCGtg-3' (antisense) for 
oligo 3.
A scrambled siRNA with no significant sequence 
homology to all mouse, rat, or human gene sequences was used 
as the negative control. The day before transfection, the cells 
were plated in 6-well plates (5x104 cells/well). One hundred 
picomoles of the duplex siRNAs was transfected into the cells 
using 4 µl of Lipofectamine 2000 (Thermo Fisher Scientific). 
After 72 h, the cells were treated differently according to 
experimental design. In pilot experiments, we confirmed that 
all three transfections of siRNA for dynamin 2 and cortactin 
were effective.
Filopodial formation. H1299 cells were serum-starved for 
16 h. Thereafter, the cells were transfected with dynamin 2 
siRNAs, cortactin siRNAs, or the control siRNA, followed 
by incubation with DMEM supplemented with 10% FBS for 
45 min. For the rescue experiments, cortactin was silenced 
in H1299 cells with oligo 3, and the cells were cultured for 
24 h. The cells (1x105/coverslip) were then transfected with 
rat wild-type cortactin or cortactin W525K (0.25 µg each) 
cloned into the pIRES2-AcGFP1 expression vector (Clontech 
Laboratories, Santa Clara, CA, USA). Thereafter, the cells 
were stimulated with serum for 45 min, fixed, and stained 
with Alexa Fluor 488 or rhodamine-labeled phalloidin for 
visualization of filopodia.
Wound healing assay. H1299 cells were cultured to confluence 
on glass-bottom dishes (35 mm diameter; AGC Techno Glass 
Co. Ltd., Tokyo, Japan) in DMEM supplemented with 0.2% FBS 
INTERNATIONAL JOURNAL OF ONCOLOGY  49:  877-886,  2016 879
for 8 h. Thereafter, the cell layer was wounded with a plastic 
pipette tip as previously described (25). The cells were washed 
with DMEM supplemented with 0.2% FBS and incubated for 
8 h in the presence of Dynasore, Dynole 34-2 or MitMAB at 
the indicated concentrations. For the negative control, cells 
were incubated with 1% dimethyl sulfoxide (DMSO). The cells 
were visualized by Giemsa staining, followed by the acquisi-
tion of phase contrast images from ≥20 randomly selected 
areas per dish. Areas filled with migrating cells were analyzed 
with ImageJ software (National Institutes of Health, Bethesda, 
MD, USA).
Formation of in vitro F-actin bundles. For the fluorescent 
detection of F-actin, non-muscle actin was polymerized in 
F-buffer (10 mM Tris-HCl, 0.2 mM DTT, 0.2 mM CaCl2, 
2 mM MgCl2, 50 mM KCl, and 0.5 mM ATP, pH 7.5) for 
1 h. Thereafter, 3.3 µM F-actin was incubated with 5 µM 
dynamin 1 or 2 and cortactin for 1 h, followed by an additional 
30 min with 3 µM Alexa Fluor 488-phalloidin. The samples 
were spread onto glass slides and mounted, and the F-actin 
bundles were observed under an epifluorescent microscope.
For the immunolocalization of dynamin and cortactin, 
F-actin bundles were incubated with dynamin 1 or 2 and 
cortactin for 30 min with 3 µM phalloidin to stabilize the 
filaments, followed by centrifugation at 5,000 x g for 10 min. 
The pellet was resuspended with 50 µl of F-buffer and then 
immunostained in suspension for 30 min with 1 µl of primary 
antibody. The mixture was centrifuged at 5,000 x g, and the 
pellet was washed with F-buffer. The samples were incubated 
with secondary antibodies and washed as previously done 
for the primary antibody. All steps were performed at room 
temperature. The samples were spread onto glass slides and 
mounted. The samples were examined under a spinning disc 
confocal microscope system (CSU10, Yokogawa Electric 
Co., Tokyo, Japan) combined with an inverted microscope 
(IX-71, Olympus Optical Co., Ltd., Tokyo, Japan) and a 
CoolSNAP-HQ camera (Roper Technologies, Sarasota, FL, 
USA). The confocal system was controlled by MetaMorph 
software (Molecular Devices, Sunnyvale, CA, USA). Images 
were processed using Adobe Photoshop CS3 or Illustrator CS3 
software.
Immunoprecipitation assay. For the immunoprecipitation 
assay, H1299 cells were co-transfected with GFP-tagged 
dynamin 2 and either myc-tagged cortactin or cortactin ∆SH3. 
The cells were lysed with 1% NP-40, 100 mM KCl, 0.5 mM 
EDTA, 10 mM NaF, and 20 mM HEPES/KOH, pH 7.4, and a 
protease inhibitor cocktail tablet (Roche Diagnostics, Basel, 
Switzerland). The protein complexes were immunoprecipitated 
from 1 mg of cell extract using either 5 µg of the polyclonal 
anti-myc antibodies or preimmune IgG, and then visualized 
by western blotting with a monoclonal anti-GFP or anti-myc 
antibody.
Immunostaining and fluorescent microscopy. H1299 cells 
were fixed with 4% paraformaldehyde and stained by immu-
nofluorescence as previously described (12).
Transmission electron microscopy. Specimens were embedded 
for immunoelectron microscopy as previously described (12). In 
brief, H1299 cells were fixed with cytoskeleton buffer (10 mM 
2-(N-morpholino)ethanesulfonic acid, 150 mM NaCl, 5 mM 
EGTA, 5 mM MgCl2, and 5 mM glucose, pH 6.0) containing 
10 µg/ml phalloidin, 0.1% Triton X-100, and 3% formaldehyde 
for 1 min. The cells were then fixed for an additional 30 min 
without Triton X-100, followed by washing with 5 µg/ml phal-
loidin in phosphate-buffered saline (PBS). After incubation 
in blocking solution (10 µg/ml phalloidin, 2 mg/ml BSA, and 
100 mM glycine in PBS), the specimens were incubated with 
a primary antibody diluted in blocking solution, washed with 
5 µg/ml phalloidin in PBS, incubated with goat anti-mouse or 
rabbit anti-goat IgG conjugated to 10-nm gold particles, and 
then fixed with 2.5% glutaraldehyde and 5 µg/ml phalloidin in 
PBS. The specimens were post-fixed with 1% OsO4 in 0.1 M 
sodium cacodylate buffer for 1 h, dehydrated, and embedded 
in EPON 812 for ultrathin sectioning. Cross-sections were 
visualized under a Hitachi H-7100 transmission electron 
microscope.
Determination of filopodial length. For the measurement 
of the filopodial length, H1299 cells were fixed and stained 
with rhodamine- or Alexa Fluor 488-conjugated phalloidin. 
Membrane protrusions supported with F-actin bundles were 
defined as filopodia, and digital images were acquired at 
400-1,000x magnifications. Up to five filopodia for each cell 
were randomly selected, and their lengths were measured with 
ImageJ software.
Statistical analysis. Data were analyzed for statistical 
significance using KaleidaGraph software (version 4.1) for the 
Macintosh (Synergy Software Inc., Essex Junction, VT, USA). 
Analysis of variance and Tukey's honest significant difference 
post hoc test were applied for more than two different groups, 
and Student's t-test was applied for two different groups. 
P-values of <0.05 and 0.001 were considered as statistically 
significant.
Results
Inhibition of dynamin decreases the migration of the human 
non-small cell lung carcinoma cell line H1299. To determine 
whether dynamin 2 is involved in cell migration, the effects 
of dynamin inhibition on cell migration were determined by a 
wound healing assay. Cell migration decreased after treatment 
of cells with Dynasore (26), Dynole 34-2 (27), and MitMAB 
(28) (Fig. 1A). Dynasore (80 µM) inhibited cell migration by 
~80% compared to that of control cells, whereas Dynole 34-2 
and MitMAB inhibited cell migration by 20-40% (Fig. 1B). 
These results indicate that dynamin is important for the migra-
tion of H1299 cells.
Dynamin 2 colocalizes with cortactin along F-actin bundles in 
filopodia of H1299 cells. Fig. 1 shows that dynamin is involved 
in cell migration mediated by pseudopodia. Thus, we investi-
gated whether dynamin 2 participates in filopodial formation 
in H1299 cells. Because cortactin functions with dynamin 1 
in the bundling of F-actin, which is important for the stability 
of filopodia in human neuroblastoma cell line SH-SY5Y (12), 
dynamin 2 and cortactin were immunostained in serum-stimu-
lated H1299 cells. H1299 cells formed numerous filopodia 
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after serum stimulation (Fig. 2A). Furthermore, dynamin 2 
and cortactin colocalized to F-actin bundles in filopodia 
as bright dots (Fig. 2A). The negative controls showed little 
immunoreactivity for dynamin 2 and cortactin (Fig. 2B). In 
addition, immunoelectron microscopy revealed that both 
proteins localized to F-actin bundles in filopodia (Fig. 2C).
These results prompted us to examine the possible inter-
action of dynamin 2 and cortactin by immunoprecipitation. 
Exogenously expressed dynamin 2-GFP was co-precipitated 
with full-length cortactin-myc using a polyclonal anti-myc anti-
bodies and H1299 cell lysates (Fig. 2D, left). Cort ∆SH3-myc, a 
dynamin 2 binding deficient mutant that lacks its SH3 domain, 
was unable to precipitate dynamin 2 (Fig. 2D, right). Taken 
together, these results illustrate that these proteins interact at 
F-actin bundles in filopodia of H1299 cells.
Dynamin 2 and cortactin are required for serum-induced 
filopodial formation in H1299 cells. To examine the role of 
dynamin 2 in filopodial formation, dynamin 2 was silenced in 
H1299 cells by RNAi. Compared with the control, knockdown 
of dynamin 2 in H1299 cells with specific siRNAs reduced 
its level by ~95% as revealed by western blotting (Fig. 3A). 
Compared with the length of filopodia in serum-stimulated 
control cells (10.2±0.5 µm), dynamin 2 knockdown decreased 
filopodial extension in silenced cells (4.7±0.6 µm) (Fig. 3B 
and C). In addition, dynasore inhibited filopodial extension 
(2.4±0.08 µm). This effect was rescued after the inhibitor was 
removed (8.1±2.4 µm) (Fig. 3D and E).
We also examined the effects of cortactin knockdown by 
RNAi on filopodial formation. Compared with the control, 
knockdown of cortactin reduced its level by ~95% as revealed 
by western blotting (Fig. 4A). Compared with the length of 
filopodia in control cells (10.2±0.39 µm), cortactin knockdown 
also decreased filopodial extension after serum-stimulation 
(5.6±0.17 µm) (Fig. 4B and C). The inhibition of filopodial 
formation in cortactin-silenced cells was rescued by exogenous 
expression of wild-type cortactin (10.8±0.54 µm) but not by 
cortactin W525K, a binding-defective mutant of dynamin 2 
(29) (Fig. 4D and E). In addition, the punctate-like localization 
of dynamin 2 along F-actin bundles reappeared in wild-type 
cortactin expressing cells (Fig. 4F, right). These results indi-
cate that dynamin 2 and cortactin are required for filopodial 
formation.
F-actin bundling by the dynamin 2-cortactin complex stabi-
lizes F-actin. The effects of dynamin 2 and cortactin on the 
formation of F-actin bundles were examined in vitro. In this 
experiment, preformed F-actin were incubated with or without 
cortactin and dynamin 2 in the presence of GTP. F-actin alone 
appeared as uniform filaments (Fig. 5A, actin alone). The 
addition of dynamin 2 to F-actin filaments did not cause any 
visible change in their distribution (Fig. 5A, + Dyn2). However, 
F-actin incubated with wild-type cortactin, cortactin W525K 
or cortactin ∆SH3 often formed small clusters (Fig. 5A, + Cort 
WT, + Cort W525K, or + Cort ∆SH3), consistent with a previ-
ously published report (12). The presence of both dynamin 2 
Figure 1. Dynamin GTPase inhibitors inhibit the migration of H1299 cells. (A) Representative images acquired by light microscopy showing cell migration in a 
wound healing assay. Confluent H1299 cells were wounded and then incubated for 8 h in the presence or absence of dynamin GTPase inhibitors at the indicated 
concentrations. For the negative control (control 0 h), cells were incubated with 1% DMSO. Scale bar, 200 µm. (B) Morphometric analysis of the wound area 
filled by migrating cells after treatment with inhibitors at the indicated concentrations. The changes were normalized to the control. Results represent the 
means ± SEM of three independent experiments.
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and wild-type cortactin resulted in the formation of long and 
thick F-actin bundles (Fig. 5A, + Dyn2 + Cort WT), which 
were similar to those formed by dynamin 1 and cortactin 
(Fig. 5A, + Dyn1 + Cort WT). On the other hand, the long and 
thick F-actin bundles were much less evident in the presence 
of dynamin 2 and cortactin W525K or ∆SH3 (Fig. 5A, + Dyn2 
+ Cort W525K or + Dyn2 + Cort ∆SH3).
To localize dynamin 2 and cortactin to F-actin bundles, 
the preformed F-actin bundles were used for immunofluores-
cent staining. Dynamin 2 and cortactin colocalized as bright 
dots along F-actin bundles (Fig. 5B, left). The localiza-
tion of dynamin 2 and cortactin was similar to that of the 
dynamin 1-cortactin complex (Fig. 5B, right) (12).
Lastly, we examined whether actin bundling by the 
dynamin 2-cortactin complex can affect F-actin stability. 
To address this, the depolymerization kinetics of preformed 
pyrene-labeled F-actin were examined after the solution was 
diluted 10-fold with buffer. In the presence of dynamin 2 and 
cortactin, the rate of depolymerization by dilution decreased 
to a level comparable to that induced by α-actinin, an actin-
crosslinking protein, indicating that dynamin 2 and cortactin 
stabilize F-actin bundles (Fig. 5C). These results indicate that 
the dynamin 2-cortactin complex stabilizes F-actin bundles in 
filopodia prior to cell migration.
Discussion
The involvement of dynamin in the dynamics of cancer cells 
such as cell migration, invasion, and metastasis has been 
reported (18). However, the precise role of dynamin in these 
Figure 2. Dynamin 2 colocalizes with cortactin along F-actin bundles in filopodia of serum-stimulated H1299 cells. (A) Colocalization of dynamin 2 (Dyn2, 
left) and cortactin (Cort, middle) by double-immunofluorescent staining in filopodia of serum-stimulated H1299 cells. Boxed areas correspond to enlarged 
images shown below. Dynamin 2- and cortactin-positive puncta were present periodically along F-actin bundles in filopodia (arrowheads). Scale bar, 5 µm 
(upper panels), 1.6 µm (lower panels). (B) In the negative controls, the primary antibodies were omitted for dynamin 2 (left) and cortactin (right). Boxed 
areas correspond to enlarged images shown below. Bar, 10 µm (top and bottom panels), 2.8 µm (middle panels). (C) Representative images acquired by 
immunoelectron microscopy showing the localization of dynamin 2 (top three panels) and cortactin (bottom three panels) in filopodia of serum-stimulated 
H1299 cells. Immunoreactive dynamin 2 and cortactin were present along F-actin bundles (arrowheads). Scale bar, 20 nm. (D) Immunoprecipitation (IP) 
results demonstrating an in vivo interaction between dynamin 2 and cortactin. H1299 cells were co-transfected with GFP-tagged dynamin 2 (Dyn2-GFP) and 
either myc-tagged wild-type cortactin (Cort WT-myc, left) or cortactin ∆SH3 (Cort ∆SH3-myc, right). The protein complexes were immunoprecipitated using a 
polyclonal anti-myc antibody or preimmune IgG (IgG), and then visualized by western blotting (WB) with monoclonal anti-GFP or anti-myc antibodies. Total 
cell lysates (4, 10 and 20 µg) were also analyzed (input).
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cellular processes is not entirely clear. We recently reported 
that actin bundling by the dynamin 1-cortactin complex is 
crucial for neurite extension in developing neurons (12). In 
this study, we examined the possibility that a similar F-actin-
bundling mechanism is involved in the migration of H1299 
cells, a human non-small cell lung carcinoma cell line.
We showed that cortactin and dynamin 2 mostly colocal-
ized along F-actin bundles in filopodia of serum-stimulated 
H1299 cells (Fig. 2). Pharmacological inhibition of dynamin 2 
by Dynasore, Dynole 34-2 or MitMAB decreased cell migra-
tion (Fig. 1) and filopodial formation (Fig. 3). Furthermore, 
filopodia were shorter in dynamin 2- and cortactin-depleted 
cells than in control cells (Figs. 3 and 4). In cortactin-silenced 
cells, the exogenous expression of wild-type cortactin rescued 
the punctate-like localization of dynamin 2 and filopodial 
formation (Fig. 4). Both dynamin 2 and cortactin bundled 
Figure 3. Knockdown of dynamin 2 decreases filopodial formation in H1299 cells. (A) Western blotting showing knockdown of dynamin 2 (Dyn2) expression 
by RNAi in H1299 cells. β-actin served as the control. Three micrograms of cell lysate from each sample was analyzed by gel electrophoresis. (B) F-actin was 
visualized in H1299 cells by Alexa Fluor 488-phalloidin staining after knockdown of dynamin 2. Extensive filopodial formation was observed in cells after 
serum stimulation (left). Filopodial formation was inhibited in dynamin 2-silenced cells (right). Boxed areas correspond to enlarged images shown below. 
Scale bar, 20 µm (upper panels), 5 µm (lower panels). (C) Filopodial length in H1299 cells cultured in the presence or absence of serum. The cells were visual-
ized by fluorescent confocal microscopy, and filopodial length was measured as described in Materials and methods. (D) Inhibition of filopodial formation 
by dynasore in serum-stimulated H1299 cells. Serum-starved cells were incubated with 240 µM dynasore for 30 min, and then stimulated with 10% FBS for 
45 min in the presence of 240 µM dynasore (middle). Thereafter, dynasore was removed, and the cells were incubated in serum-containing medium for 45 min 
(right). For the negative control, cells were cultured in the presence of 3% DMSO (left). All steps were performed at 37˚C. (E) Analysis of filopodial formation 
in the H1299 cells shown in (D). The cells were analyzed by fluorescent confocal microscopy, and filopodial length was measured. Results in (C) and (E) 
represent the means ± SEM from three independent experiments.
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Figure 4. Knockdown of cortactin decreases filopodial formation in H1299 cells. (A) Western blotting showing knockdown of cortactin expression by RNAi in 
H1299 cells. β-actin was used as the control. Three micrograms of cell lysate from each sample was analyzed by gel electrophoresis. (B) F-actin was visualized 
in serum-stimulated H1299 cells by Alexa Fluor 488-phalloidin staining. Boxed areas correspond to enlarged images shown below. Similar to results from 
dynamin 2-depleted cells, filopodial formation decreased in cortactin-depleted cells (right). Scale bar, 20 µm (upper panels), 5 µm (lower panels). (C) Analysis 
of filopodial formation in H1299 cells cultured with or without serum. The samples were analyzed by fluorescent confocal microscopy, and the filopodial 
length was measured. (D) Expression of wild-type cortactin rescues filopodial formation. Cortactin-depleted H1299 cells were transfected with rat wild-type 
cortactin (left) or cortactin W525K (right) cloned into the pIRES2-AcGFP1 expression vector. Boxed areas correspond to enlarged images shown (middle 
panels). Transfected cells were identified by GFP expression (bottom panels). Scale bar, 20 µm (top and bottom panels), 3.5 µm (middle panels). (E) Analysis 
of filopodial formation in H1299 cells. The samples were analyzed by fluorescent confocal microscopy, and the filopodial length was measured. Results in (C) 
and (E) represent the means ± SEM from three independent experiments. (F) Rescue of the punctate-like localization of dynamin 2 along F-actin bundles in 
filopodia by re-expression of cortactin in cortactin-depleted cells. Cortactin-depleted H1299 cells (left panels) were transfected with rat wild-type cortactin or 
cortactin W525K cloned into the pIRES2-AcGFP1 expression vector (right panels). The cells were immunostained with an anti-dynamin 2 antibodies. Boxed 
areas correspond to enlarged images shown below. Transfected cells were identified by GFP expression (right bottom panels). Scale bar, 5 µm (top and right 
bottom panels), 2.3 µm (left bottom and right middle panels).
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F-actin, and these proteins increased F-actin stability (Fig. 5). 
These results indicate that dynamin 2 and cortactin partici-
pate in cancer cell migration by stabilizing F-actin bundles in 
filopodia.
Dynamin assembles at the neck of deeply invaginated 
endocytic pits (30). Upon GTP hydrolysis, however, dynamin 
undergoes a conformational change, resulting in the fission 
of endocytic pits and release of endocytic vesicles (31-33). In 
addition, dynamin 1 forms a ring-like complex with cortactin, 
which switches from an open to a closed state upon GTP 
hydrolysis. This change promotes the bundling of F-actin 
filaments (12). The mechanism of actin bundling mediated 
by the dynamin 2-cortactin complex is similar to that of the 
dynamin 1-cortactin complex, because dynamin 2 and cortactin 
also facilitated the formation of long and thick F-actin bundles 
to which they colocalized (Fig. 5). This mechanochemical 
Figure 5. Actin bundling by dynamin 2 and cortactin stabilizes F-actin bundles. (A) Long F-actin bundles were formed in the presence of dynamin 2 
and cortactin (lower left). Preformed F-actin (3.3 µM) was incubated with or without the indicated proteins (5 µM each). F-actin was visualized with 
Alexa Fluor 488-phalloidin. Scale bar, 30 µm. (B) Representative images acquired by fluorescent microscopy showing the localization of dynamin and 
cortactin along F-actin bundles. Actin bundles were formed in vitro by incubating dynamin 2 with wild-type cortactin (left) or dynamin 1 and wild-type 
cortactin (right). Protein colocalization was performed by double-immunofluorescence. Scale bar, 2 µm. (C) Kinetics of F-actin disassembly induced in 10-fold 
diluted preformed pyrene-labeled F-actin solution with buffer. F-actin bundles disassembled in the presence of dynamin 2 and cortactin, as well as in the 
presence of 5 µM α-actinin. The rate of F-actin bundle disassembly was measured by pyrene-fluorescence.
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property may be critical for the formation of F-actin bundles 
in filopodia of other cell types as well (Fig. 6). Additional 
studies are needed to determine the precise mechanism.
Dynamin associates with tumorigenesis, particularly tumor 
cell migration and invasion. For example, increased dynamin 2 
expression potentiates the migration and invasion of pancreatic 
ductal cancer cells (25), and tyrosine phosphorylated dynamin 2 
promotes the growth and invasiveness of glioblastomas (34). 
Thus, the involvement of dynamin in the formation of F-actin 
bundles might promote cancer malignancy.
In conclusion, we showed that dynamin 2 and cortactin 
participate in the formation of F-actin bundles, which stabi-
lize filopodia in migrating cancer cells. Taken together, these 
results suggest that dynamin might be a potential molecular 
target for anticancer therapy.
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